Information date: 7 September 2026 — China’s official business-service information distinguishes market-entry procedures and business forms; a representative office and a foreign-invested company do not provide the same capacity to contract, invoice, hire or earn revenue. Knowing that statement is not enough for an operating, research or compliance decision. The team must first establish who and what it applies to, how the effect reaches the real process, and which evidence would justify action.
Verified facts and scope
China’s official business-service information distinguishes market-entry procedures and business forms; a representative office and a foreign-invested company do not provide the same capacity to contract, invoice, hire or earn revenue.
The checklist should begin with intended activities, customers, hiring, invoicing, imports, intellectual property, premises and funding. Entity choice follows the operating model rather than preceding it.
How the effect reaches operations
A representative office can support liaison within its legal limits, while a company can conduct approved business under its registered scope. The choice changes registration, tax, banking, employment and exit work.
Choosing the lighter form only for speed may leave the team unable to receive revenue or execute the intended contracts. Choosing a company without a real budget and governance owner creates dormant-compliance cost.
For “China Entry Checklist Case: Test a Representative Office Against a Subsidiary Before Filing”, official rules or published findings, direct evidence from the relevant product or process, and assumptions that remain untested should be recorded separately. A broad source defines the external boundary; it does not replace batch records, protocols, contracts, labels or direct observations.
Decision
Select the form that can legally perform the first twelve months of real activity. If neither the activity map nor funding owner is clear, postpone filing and validate the market through a lawful alternative.
Implementation checklist
- Write five representative transactions the China operation must perform in year one.
- Compare each transaction against contracting, invoicing, hiring, import and payment capability.
- Price establishment, annual compliance and closure under both options before approval.
- Assign one decision owner, one implementation owner and a dated review point for “China Entry Checklist Case: Test a Representative Office Against a Subsidiary Before Filing”.
- For “China Entry Checklist Case: Test a Representative Office Against a Subsidiary Before Filing”, archive the source page, access date, applicable population or entity, and internal evidence both supporting and opposing the current decision.
- When a rule, formulation, supplier, protocol or observed result changes, reopen only the affected question in “China Entry Checklist Case: Test a Representative Office Against a Subsidiary Before Filing”.
Evidence and review
For “China Entry Checklist Case: Test a Representative Office Against a Subsidiary Before Filing”, start with one real case rather than an abstract checklist. Record the input version, responsible owner, start time, observed result and stop condition. If the team cannot complete “Write five representative transactions the China operation must perform in year one.” with current evidence, it should not expand the process to more products, patients, suppliers or markets. The first review should focus only on facts capable of changing the decision.
The second control follows “Compare each transaction against contracting, invoicing, hiring, import and payment capability.”. Keep the source date, applicable population or entity, deadline, cost effect and owner in the same evidence file. A wording preference does not justify a new version. A repeated discrepancy, an unsupported health claim or a regulatory mismatch does: correct that point and hold release until the evidence is available.
After “Price establishment, annual compliance and closure under both options before approval.”, compare the intended outcome with what actually happened. Apply the same success criteria to each later expansion. If only one number, date or responsibility changes, update that field and the affected conclusion instead of recreating evidence that remains valid. This keeps the decision traceable without turning review into an open-ended rewrite cycle.
Counter-scenario and ownership
The review must also test the opposite of the expected outcome. If “A representative office can support liaison within its legal limits, while a company can conduct approved business under its registered scope. The choice changes registration, tax, banking, employment and exit work.”, the record should already identify who detects it, who can pause the process, and who communicates with affected people or authorities. Direct, current evidence about the studied product, population or transaction takes priority when it conflicts with a broad market statement. Keep both the approval reason and the rejection reason. Later evidence should reopen only the affected question, not trigger an unsupported rewrite of findings that still hold.
Limits of the conclusion
This is an illustrative decision case, not a report of a named company or legal conclusion. Activity and location can change registration requirements.
